Medication reconciliation upon admission in paediatric hospital setting: preliminary data

Dolores Pilar Iturgoyen Fuentes1, Sagrario Martin-Aragon2, Margarita Cuervas-Mons Vendrell3

  • 1Servicio de Farmacia, Hospital Infantil Universitario «Niño Jesús», Av. Menéndez Pelayo 65, 28009, Madrid, Spain. dolorespilar.iturgoyen@salud.madrid.org.

Insights

Medication reconciliation in pediatric patients is crucial, as 15% of children experienced medication errors, primarily omissions, upon hospital admission. This highlights the need for systematic medication reconciliation in pediatric care to improve patient safety.

Area of Science:

  • Pediatric Pharmacology
  • Patient Safety
  • Medication Management

Background:

  • Medication reconciliation benefits are established in adults but not extensively studied in pediatric patients.
  • Children with chronic illnesses often have complex medication regimens, increasing error risk.
  • Specific pediatric factors contribute to a higher likelihood of medication errors.

Purpose of the Study:

  • To evaluate the benefit of medication reconciliation for pediatric patients upon hospital admission.
  • To identify and reduce prescribing errors during the admission process in a pediatric setting.

Main Methods:

  • Pharmacist-led medication reconciliation for 187 pediatric patients.
  • Analysis of discrepancies between home medication and prescribed treatment on admission.
  • Identification of underlying diseases and pharmacotherapeutic groups associated with errors.

Main Results:

  • 42% of patients had at least one medication discrepancy; 15% had reconciliation errors (68% omissions).
  • Neurological diseases were most frequently associated with reconciliation errors (50%).
  • Key drug classes involved in errors included psychoanaleptics, anti-acids, antiepileptics, and respiratory medications.

Conclusions:

  • Medication discrepancies and errors in pediatric patients are as significant as in adults.
  • Omission of home treatments was the most common error type.
  • Implementing medication reconciliation in pediatrics can effectively reduce medication errors.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
168
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
191
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
202
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
209
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
152
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
114